Deadline: 08-Oct-2026
The Innovative Health Initiative (IHI) European HealthCare Incubator Network aims to create a sustainable European ecosystem that supports healthcare innovators during the early stages of technology development.
The network will connect:
- Academic incubators
- Healthcare innovation organisations
- Biotechnology companies
- Pharmaceutical companies
- Medical technology organisations
- Foundations
- Investors
- Venture capital organisations
- Industry partners
The objective is to create a coordinated support system that helps healthcare start-ups move from research concepts to successful market applications.
Purpose of the European HealthCare Incubator Network
The programme addresses challenges faced by early-stage healthcare innovators, including:
- Limited access to specialised expertise
- Difficulty achieving commercial readiness
- Lack of industry connections
- Challenges securing investment
- Complex regulatory pathways
- Need for healthcare system adoption
The network aims to reduce these barriers by providing structured support throughout the innovation journey.
Key Objectives of the Programme
The IHI European HealthCare Incubator Network focuses on several strategic objectives:
- Accelerating healthcare innovations from research to market
- Supporting early-stage healthcare companies
- Improving investment readiness
- Strengthening European healthcare innovation capacity
- Promoting collaboration between public and private sectors
- Supporting digital transformation in healthcare
- Advancing sustainable healthcare solutions
Priority Innovation Areas
The programme supports healthcare technologies addressing major public health challenges.
Priority areas include:
Digital Health Innovation
The initiative supports technologies that improve healthcare delivery through digital solutions.
Examples include:
- Digital healthcare platforms
- Remote patient monitoring
- Connected healthcare systems
- Data-driven healthcare tools
- Interoperable health solutions
Artificial Intelligence and Big Data
The programme encourages development of AI-powered healthcare solutions.
Potential applications include:
- AI-assisted diagnosis
- Predictive healthcare analytics
- Clinical decision-support systems
- Healthcare data interpretation
- Personalised treatment approaches
European Health Data Space Solutions
The initiative supports innovations aligned with the European Health Data Space framework.
Relevant areas include:
- Secure health data exchange
- Interoperability
- Responsible data use
- Healthcare data infrastructure
- Cross-border health innovation
Biotechnology and Life Sciences
The programme supports biotechnology-driven healthcare innovations.
Examples include:
- New therapeutic technologies
- Advanced biomedical solutions
- Disease prevention approaches
- Precision medicine applications
Medical Technologies and Healthcare Devices
The network supports medical technology innovations that improve healthcare outcomes.
Examples include:
- Medical devices
- Diagnostic technologies
- Monitoring systems
- Healthcare delivery tools
Support Provided to Healthcare Start-Ups
Selected start-ups will receive comprehensive support designed to improve technological, business, and market readiness.
Support includes:
- Mentorship from industry experts
- Access to specialised infrastructure
- Business development guidance
- Training opportunities
- Networking with investors
- Commercialisation support
- Regulatory guidance
- Industry validation opportunities
Financial Support to Third Parties (FSTP)
A major component of the programme is the Financial Support to Third Parties (FSTP) mechanism.
This provides selected healthcare start-ups with:
- Agile financial support
- Resources for innovation development
- Access to expert services
- Additional acceleration opportunities
The funding mechanism is designed to help early-stage companies overcome development barriers and progress towards market readiness.
Target Companies and Technology Readiness Levels
The programme specifically targets early-stage healthcare companies operating at:
- Technology Readiness Level (TRL) 3
- Technology Readiness Level (TRL) 4
- Technology Readiness Level (TRL) 5
These companies are expected to have moved beyond initial research and are actively developing and validating their technologies.
Understanding TRL 3 to TRL 5
TRL 3: Experimental Proof of Concept
At this stage, companies have demonstrated early evidence that their technology concept can work.
Examples include:
- Initial laboratory validation
- Prototype development
- Early technical demonstrations
TRL 4: Technology Validation in Laboratory Environment
Companies are testing whether their technology performs reliably under controlled conditions.
Examples include:
- Prototype testing
- Technical refinement
- Performance evaluation
TRL 5: Technology Validation in Relevant Environment
Companies are moving closer to practical application.
Examples include:
- Real-world testing
- Healthcare environment validation
- Improved prototype development
Industry Validation and Quality Seal
The programme aims to provide successful start-ups with an industry quality seal after completing validation activities.
This recognition can help companies:
- Improve investor confidence
- Increase credibility with healthcare organisations
- Demonstrate market readiness
- Strengthen regulatory engagement
- Attract venture capital investment
Building a European Healthcare Innovation Ecosystem
The network promotes collaboration between:
- Start-ups
- Healthcare providers
- Research institutions
- Pharmaceutical companies
- Medical technology companies
- Investors
- Government stakeholders
These partnerships help innovative companies develop stronger:
- Business models
- Technology strategies
- Market approaches
- Commercialisation plans
Collaboration With European Innovation Programmes
The initiative will work closely with existing European and national innovation programmes.
This collaboration aims to help start-ups:
- Identify additional funding opportunities
- Access complementary support programmes
- Expand innovation networks
- Accelerate market entry
Contribution to EU Healthcare Strategies
The programme supports major European priorities related to:
- Life sciences
- Biotechnology
- Pharmaceuticals
- Digital health
- Cancer innovation
- Non-communicable disease prevention
- Healthcare system transformation
Funding Details
Key funding information includes:
- Total available budget: €53.2 million
- Funding programme: Innovative Health Initiative (IHI)
- Application process: Two-stage submission process
- Call opening date: 2 July 2026
Expected indicative project contributions include:
- Approximately €9 million
- Approximately €9.2 million
- Approximately €35 million
Final funding decisions depend on proposal quality, evaluation results, and project scope.
Application Timeline
Important dates include:
- Call opening: 2 July 2026
- First-stage application deadline: 8 October 2026
- Second-stage full proposal deadline: 21 April 2027
Applicants must submit proposals electronically through the EU Funding & Tenders Portal.
Who Can Apply?
Participation is open to eligible legal entities that meet Horizon Europe requirements.
Eligible applicants may include:
- Universities
- Research organisations
- Healthcare incubators
- Biotechnology companies
- Pharmaceutical organisations
- Medical technology companies
- Innovation networks
- Other eligible organisations
Applicants must comply with:
- Horizon Europe eligibility rules
- Call-specific requirements
- Application admissibility conditions
How the Application Process Works
Step 1: Develop a Collaborative Consortium
Applicants should build partnerships involving relevant healthcare innovation stakeholders.
Strong consortia may include:
- Incubators
- Industry partners
- Investors
- Research organisations
- Healthcare institutions
Step 2: Define the Network Strategy
Proposals should explain:
- How incubators will collaborate
- How start-ups will be supported
- How funding mechanisms will operate
- How market readiness will improve
Step 3: Describe Support Services
Applicants should outline:
- Mentorship programmes
- Training activities
- Infrastructure access
- Industry engagement
- Investment preparation support
Step 4: Submit Through the EU Funding Portal
Applications must be:
- Submitted electronically
- Completed using official forms
- Submitted before deadlines
- Compliant with Horizon Europe requirements
Step 5: Project Implementation
Selected projects will:
- Establish the incubator network
- Support healthcare start-ups
- Provide funding and services
- Build industry partnerships
- Promote commercialisation
Common Mistakes Applicants Should Avoid
Applicants should avoid:
- Failing to demonstrate healthcare impact
- Weak plans for start-up support
- Limited industry involvement
- Unclear commercialisation pathways
- Poor explanation of incubator collaboration
- Ignoring regulatory and market challenges
Tips for a Strong Application
Applicants can strengthen proposals by:
- Demonstrating strong European collaboration
- Including experienced healthcare innovation partners
- Providing clear start-up support strategies
- Explaining investment readiness activities
- Showing links to EU healthcare priorities
- Defining measurable outcomes
- Including sustainability plans beyond project funding
Frequently Asked Questions (FAQ)
What is the IHI European HealthCare Incubator Network?
The IHI European HealthCare Incubator Network is a European initiative that connects healthcare incubators and supports early-stage healthcare companies through funding, mentorship, expertise, and commercialisation assistance.
Who does the programme support?
The programme supports early-stage healthcare companies developing innovative technologies, particularly those operating at Technology Readiness Levels 3 to 5.
What types of healthcare innovations are supported?
The programme supports digital health, artificial intelligence, big data, biotechnology, medical technologies, interoperable health solutions, and other healthcare innovations addressing unmet health needs.
What is Financial Support to Third Parties (FSTP)?
FSTP is a funding mechanism that provides financial support directly to selected third-party beneficiaries, such as healthcare start-ups, to help accelerate innovation development.
How much funding is available?
The total budget available under the call is €53.2 million, with expected project contributions of approximately €9 million, €9.2 million, and €35 million.
How do companies benefit from the network?
Participating companies gain access to mentorship, investors, industry expertise, training, infrastructure, and support to improve technology and business readiness.
How do organisations apply?
Applicants must submit electronic proposals through the EU Funding & Tenders Portal following Horizon Europe requirements and the specific call guidelines.
Conclusion
The IHI European HealthCare Incubator Network provides a major opportunity to strengthen Europe’s healthcare innovation ecosystem by connecting incubators, investors, researchers, and industry partners.
By supporting early-stage healthcare companies with funding, expertise, mentorship, and commercialisation pathways, the initiative aims to accelerate the development of impactful healthcare technologies and bring innovative solutions closer to patients and healthcare systems across Europe.
For more information, visit European Commission.